Spikevax XBB.1.5 0.1 mg/mL▼(andusomeran) dispersion for injection

Spikevax XBB.1.5 is indicated for:

Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

SUMMARY OF PRODUCT CHARACTERISTICS

PATIENT INFORMATION LEAFLET

For Product Quality Complaints, General Questions, and Healthcare Professional Medical Inquiries:

• Call Moderna: 0800 085 7562 (Monday to Friday, 09.00 to 17.00 GMT, not including holidays)

• Email Moderna: WeCare@modernatx.com